MedPath

Effect of Delayed Cord Clamping in Preterm Neonates With Placental Insufficiency

Not Applicable
Completed
Conditions
Preterm Infant
Placental Insufficiency
Placental Transfusion
Interventions
Procedure: Delayed cord clamping
Registration Number
NCT03731546
Lead Sponsor
Mansoura University Children Hospital
Brief Summary

To investigate the effect of delayed cord clamping (DCC) on hematopoietic progenitor cells (HPCs), hematological parameters including haemoglobin concentration and hematocrit value in premature infants (34 weeks gestational age or less) with placental insufficiency.We hypothesized that preterm infants with placental insufficiency underwent DDC could have better hematologic parameters and hematopoietic progenitor cells compared to immediate cord clamping.

Detailed Description

• A prospective randomized controlled study will be performed on preterm infants 34 weeks gestational age or less with placental insufficiency, and those without placental insufficiency where DCC will be performed in both groups. A third group of preterm with placental insufficiency and immediate cord clamping will be performed as a control.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
90
Inclusion Criteria
  • preterm neonates < 34 weeks gestational age
Exclusion Criteria
  • Vaginal bleeding due to placental abruption or tears Multiple pregnancies Suspected major fetal anomalies Suspected chromosomal aberration Maternal drug abuse Hydrops fetalis preterm who needed major resuscitative measures

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Group BDelayed cord clampingPlacental insufficiency and DCC: Cord clamping 60 seconds after delivery of fetus in preterm infants with placental insufficiency
Group CDelayed cord clampingNormal placenta with DCC:Cord clamping 60 seconds after delivery of fetus in preterm infants without placental insufficiency
Primary Outcome Measures
NameTimeMethod
Peripheral venous CD34 at admissionfirst 24 hours of infants' life

One milliliter of fetal blood will be taken from peripheral venous blood in the first 30 minutes of life and CD34 will be assessed by flow cytometry.

Secondary Outcome Measures
NameTimeMethod
Hemoglobin at 2 months2 months of infants' life

One milliliter of neonatal blood will be taken from peripheral venous blood at 2 months of life.

Intraventricular hemorrhagefirst 28 days of life
Retinopathy of prematurityfirst 28 days of life
Admission hemoglobinfirst 24 hours of infants' life

One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.

Polycythemiafirst 28 days of life
Necrotizing enterocolitisfirst 28 days of life
Duration of oxygen therapyfirst 28 days of life
Bronchopulmonary dysplasiafirst 70 days of life
Need for nasal CPAPfirst 28 days of life
Admission plateletsfirst 24 hours of infants' life

One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24 hours of life.

Culture proven sepsisfirst 28 days of life
Need for mechanical ventilationfirst 28 days of life
Need for inotropesfirst 28 days of life
Need for packed RBCs transfusionfirst 28 days of life
Admission WBCsfirst 24 hours of infants' life

One milliliter of neonatal blood will be taken from peripheral venous blood in the first 24

Phototherapy requirementsfirst 28 days of life

Trial Locations

Locations (1)

Mansoura University Children's Hospital

🇪🇬

Mansourah, Egypt

© Copyright 2025. All Rights Reserved by MedPath